PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Aug 24, 2026, 3:35 PM

Roche outlays $2.3bn for Hanmi’s non-GLP-1 obesity candidate

The licensing deal marks a diversification of Roche’s obesity pipeline as it seeks entry into the lucrative market.

ET Pharma

Aug 24, 2026, 12:54 PM

Jubilant Pharmova’s US facility Line 3 gets FDA nod for commercial production

The new Isolator based fill and finish line has a total annual production capacity of 55 million units and equipped with three compounding suites with capacity for up to 2000 L bulks and disposable, single-use compounding and filling technologies.

PharmaShots

Aug 24, 2026, 12:30 PM

Roche’ Elecsys pTau217 Test Receives the US FDA Clearance to Rule in or Rule Out Alzheimer’s-Related Amyloid Pathology

Shots: Ref: Globenewswire  |  Image: Roche  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Roche’ Elecsys pTau217 Test Receives the US FDA Clearance to Rule in or Rule Out Alzheimer’s-Related Amyloid Pathology appeared first on PharmaShots.

Express Pharma

Aug 24, 2026, 11:48 AM

India Pharma Archives launched at IIM Ahmedabad

Developed by IIM Ahmedabad Archives and supported by the Indian Pharmaceutical Alliance, India Pharma Archives captures the people, institutions and milestones behind the evolution of one of India’s most globally significant industries. The post India Pharma Archives launched at IIM Ahmedabad appeared first on Express Pharma.

Pharma Tech

Aug 24, 2026, 11:43 AM

Reaching maturity: A roadmap for Quality Excellence amid regulatory transformation

A convergence of regulations across life sciences has shifted quality management from a burden into an imperative for excellence.

PharmaShots

Aug 24, 2026, 11:30 AM

Takeda Reports MHLW Approval of Orzeyful (Oveporexton) for Narcolepsy Type 1

Shots: Ref: Businesswire  |  Image: Takeda  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Takeda Reports MHLW Approval of Orzeyful (Oveporexton) for Narcolepsy Type 1 appeared first on PharmaShots.

News

Latest industry coverage

Google News

Aug 25, 2026, 4:18 AM

Young startups miss out on biotech venture funding rebound, MassBio says - BioPharma Dive

Young startups miss out on biotech venture funding rebound, MassBio says  BioPharma Dive

Google News

Aug 25, 2026, 4:14 AM

FDA logs more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide - drugdiscoverytrends.com

FDA logs more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide  drugdiscoverytrends.com

Google News

Aug 25, 2026, 4:08 AM

Preparing for Novartis showdown, Curium touts value of radiopharma supply resiliency - BioSpace

Preparing for Novartis showdown, Curium touts value of radiopharma supply resiliency  BioSpace

Google News

Aug 25, 2026, 4:05 AM

Biotech jobs dropped for the first time in 2025. Can rebounding VC, M&A bring them back? - The Business Journals

Biotech jobs dropped for the first time in 2025. Can rebounding VC, M&A bring them back?  The Business Journals

Google News

Aug 25, 2026, 4:01 AM

Massachusetts lost biotech jobs for first time in 2025, new report shows - The Boston Globe

Massachusetts lost biotech jobs for first time in 2025, new report shows  The Boston Globe

Google News

Aug 25, 2026, 2:56 AM

From biomedical discovery to medicines: How Israel can turn research into biotech success - Ynetnews

From biomedical discovery to medicines: How Israel can turn research into biotech success  Ynetnews

Google News

Aug 25, 2026, 2:21 AM

Daewoong Moves Ahead on Indonesia Halal Market - Businesskorea

Daewoong Moves Ahead on Indonesia Halal Market  Businesskorea

Google News

Aug 25, 2026, 1:02 AM

Piramal Pharma Acquires Controlling Stake in Yapan Bio - Machine Maker

Piramal Pharma Acquires Controlling Stake in Yapan Bio  Machine Maker

Google News

Aug 25, 2026, 12:30 AM

Indian Stock Market News, Equity Market and Sensex Today in India - Equitymaster

Indian Stock Market News, Equity Market and Sensex Today in India  Equitymaster

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer